
Cassel Salpeter & Co.’s Q3 healthcare update points to disrupted NIH grant processing, FDA attrition, and tariffs as pressures on drug development and early-stage financing.
Proven Methods for Reducing Change Orders and Assessing Their Impact
Join Lisa Henderson, Editor in Chief of Applied Clinical Trials, and Mindy Davis, Director, Clinical Services at ClearTrial, as they discuss how forward-thinking biopharmaceutical and medical device companies are reducing change orders during clinical trials – and how they are managing change orders more effectively when they do occur.






